Design of prodrugs:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Amsterdam u.a.
Elsevier
1985
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | VII, 360 S. |
ISBN: | 044480675X |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV000463494 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 870612s1985 |||| 00||| eng d | ||
020 | |a 044480675X |9 0-444-80675-X | ||
035 | |a (OCoLC)12263235 | ||
035 | |a (DE-599)BVBBV000463494 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-12 |a DE-355 | ||
050 | 0 | |a RM301.57 | |
082 | 0 | |a 615/.191 |2 19 | |
084 | |a VS 5450 |0 (DE-625)147692:253 |2 rvk | ||
245 | 1 | 0 | |a Design of prodrugs |c ed. by Hans Bundgaard |
264 | 1 | |a Amsterdam u.a. |b Elsevier |c 1985 | |
300 | |a VII, 360 S. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
650 | 4 | |a Chimie pharmaceutique | |
650 | 4 | |a Médicaments - Métabolisme | |
650 | 4 | |a Promédicaments | |
650 | 4 | |a Biopharmaceutics | |
650 | 4 | |a Biotransformation | |
650 | 4 | |a Chemistry, Pharmaceutical | |
650 | 4 | |a Drugs |x Metabolism | |
650 | 4 | |a Pharmaceutical chemistry | |
650 | 4 | |a Prodrugs | |
650 | 0 | 7 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pro-Pharmakon |0 (DE-588)4193853-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Biotransformation |0 (DE-588)4006908-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Kontrollierte Wirkstofffreisetzung |0 (DE-588)4165181-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Pro-Pharmakon |0 (DE-588)4193853-7 |D s |
689 | 0 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Pro-Pharmakon |0 (DE-588)4193853-7 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
689 | 2 | 1 | |a Biotransformation |0 (DE-588)4006908-4 |D s |
689 | 2 | |5 DE-604 | |
689 | 3 | 0 | |a Kontrollierte Wirkstofffreisetzung |0 (DE-588)4165181-9 |D s |
689 | 3 | |5 DE-604 | |
689 | 4 | 0 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |D s |
689 | 4 | |5 DE-604 | |
700 | 1 | |a Bundgaard, Hans |e Sonstige |4 oth | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000285461&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-000285461 |
Datensatz im Suchindex
_version_ | 1804114916684070912 |
---|---|
adam_text | 01 DESIGN OF PRODRUGS EDITED BY HANS BUNDGAARD 1985 ELSEVIER AMSTERDAM
- NEW YORK - OXFORD CONTENTS PREFACE V CHAPTER 1. DESIGN OF PRODRUGS:
BIOREVERSIBLE DERIVATIVES FOR VARIOUS FUNC- TIONAL GROUPS AND CHEMICAL
ENTITIES, BY H. BUNDGAARD 1 CHAPTER 2. DESIGN OF PRODRUGS BASED ON
ENZYME-SUBSTRATE SPECIFICITY, BY P.K. BANERJEE AND G.L. AMIDON 93
CHAPTER 3. PHARMACOKINETIC ASPECTS OF PRODRUG DESIGN AND EVALUATION, BY
R.E. NOTARI 135 CHAPTER 4. SUSTAINED DRUG ACTION ACCOMPLISHED BY THE
PRODRUG APPROACH, BY A.A. SINKULA 157 CHAPTER 5. SITE-SPECIFIC DRUG
DELIVERY VIA PRODRUGS, BY V.J. STELLA AND K.J. HIMMELSTEIN 177 CHAPTER
6. DECREASED TOXICITY AND ADVERSE REACTIONS VIA PRODRUGS, BY G. JONES
199 CHAPTER 7. PRODRUGS FOR IMPROVED FORMULATION PROPERTIES, BY B.D.
ANDER- SON . 243 CHAPTER 8. PRODRUGS AND SKIN ABSORPTION, BY J. HADGRAFT
271 CHAPTER 9. PRODRUGS IN CANCER CHEMOTHERAPY, BY T.A. CONNORS 291
CHAPTER 10. ALBUMIN: A NATURAL CARRIER FOR DRUG AND ENZYME THERAPY, BY
M.J. POZNANSKY AND D. BHARDWAJ 317 CHAPTER 11. PRODRUGS VERSUS SOFT
DRUGS, BY N. BODOR 333 SUBJECT INDEX 355
|
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV000463494 |
callnumber-first | R - Medicine |
callnumber-label | RM301 |
callnumber-raw | RM301.57 |
callnumber-search | RM301.57 |
callnumber-sort | RM 3301.57 |
callnumber-subject | RM - Therapeutics and Pharmacology |
classification_rvk | VS 5450 |
ctrlnum | (OCoLC)12263235 (DE-599)BVBBV000463494 |
dewey-full | 615/.191 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.191 |
dewey-search | 615/.191 |
dewey-sort | 3615 3191 |
dewey-tens | 610 - Medicine and health |
discipline | Chemie / Pharmazie Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02368nam a2200637 c 4500</leader><controlfield tag="001">BV000463494</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">870612s1985 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">044480675X</subfield><subfield code="9">0-444-80675-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)12263235</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000463494</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301.57</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.191</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5450</subfield><subfield code="0">(DE-625)147692:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Design of prodrugs</subfield><subfield code="c">ed. by Hans Bundgaard</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam u.a.</subfield><subfield code="b">Elsevier</subfield><subfield code="c">1985</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VII, 360 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chimie pharmaceutique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Métabolisme</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Promédicaments</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biopharmaceutics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotransformation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemistry, Pharmaceutical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Metabolism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical chemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prodrugs</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pro-Pharmakon</subfield><subfield code="0">(DE-588)4193853-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biotransformation</subfield><subfield code="0">(DE-588)4006908-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kontrollierte Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4165181-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pro-Pharmakon</subfield><subfield code="0">(DE-588)4193853-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Pro-Pharmakon</subfield><subfield code="0">(DE-588)4193853-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Biotransformation</subfield><subfield code="0">(DE-588)4006908-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Kontrollierte Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4165181-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bundgaard, Hans</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000285461&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000285461</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV000463494 |
illustrated | Not Illustrated |
indexdate | 2024-07-09T15:14:19Z |
institution | BVB |
isbn | 044480675X |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000285461 |
oclc_num | 12263235 |
open_access_boolean | |
owner | DE-12 DE-355 DE-BY-UBR |
owner_facet | DE-12 DE-355 DE-BY-UBR |
physical | VII, 360 S. |
publishDate | 1985 |
publishDateSearch | 1985 |
publishDateSort | 1985 |
publisher | Elsevier |
record_format | marc |
spelling | Design of prodrugs ed. by Hans Bundgaard Amsterdam u.a. Elsevier 1985 VII, 360 S. txt rdacontent n rdamedia nc rdacarrier Chimie pharmaceutique Médicaments - Métabolisme Promédicaments Biopharmaceutics Biotransformation Chemistry, Pharmaceutical Drugs Metabolism Pharmaceutical chemistry Prodrugs Wirkstofffreisetzung (DE-588)4190018-2 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Pro-Pharmakon (DE-588)4193853-7 gnd rswk-swf Biotransformation (DE-588)4006908-4 gnd rswk-swf Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Pro-Pharmakon (DE-588)4193853-7 s Arzneimittelentwicklung (DE-588)4143176-5 s DE-604 Arzneimittel (DE-588)4003115-9 s Biotransformation (DE-588)4006908-4 s Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 s Wirkstofffreisetzung (DE-588)4190018-2 s Bundgaard, Hans Sonstige oth GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000285461&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Design of prodrugs Chimie pharmaceutique Médicaments - Métabolisme Promédicaments Biopharmaceutics Biotransformation Chemistry, Pharmaceutical Drugs Metabolism Pharmaceutical chemistry Prodrugs Wirkstofffreisetzung (DE-588)4190018-2 gnd Arzneimittel (DE-588)4003115-9 gnd Pro-Pharmakon (DE-588)4193853-7 gnd Biotransformation (DE-588)4006908-4 gnd Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
subject_GND | (DE-588)4190018-2 (DE-588)4003115-9 (DE-588)4193853-7 (DE-588)4006908-4 (DE-588)4165181-9 (DE-588)4143176-5 (DE-588)4143413-4 |
title | Design of prodrugs |
title_auth | Design of prodrugs |
title_exact_search | Design of prodrugs |
title_full | Design of prodrugs ed. by Hans Bundgaard |
title_fullStr | Design of prodrugs ed. by Hans Bundgaard |
title_full_unstemmed | Design of prodrugs ed. by Hans Bundgaard |
title_short | Design of prodrugs |
title_sort | design of prodrugs |
topic | Chimie pharmaceutique Médicaments - Métabolisme Promédicaments Biopharmaceutics Biotransformation Chemistry, Pharmaceutical Drugs Metabolism Pharmaceutical chemistry Prodrugs Wirkstofffreisetzung (DE-588)4190018-2 gnd Arzneimittel (DE-588)4003115-9 gnd Pro-Pharmakon (DE-588)4193853-7 gnd Biotransformation (DE-588)4006908-4 gnd Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
topic_facet | Chimie pharmaceutique Médicaments - Métabolisme Promédicaments Biopharmaceutics Biotransformation Chemistry, Pharmaceutical Drugs Metabolism Pharmaceutical chemistry Prodrugs Wirkstofffreisetzung Arzneimittel Pro-Pharmakon Kontrollierte Wirkstofffreisetzung Arzneimittelentwicklung Aufsatzsammlung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000285461&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT bundgaardhans designofprodrugs |